Blood group A mothers are more likely to develop anemia during antenatal intravenous immunoglobulin treatment of fetal and neonatal alloimmune thrombocytopenia Academic Article uri icon

Overview

MeSH Major

  • Anemia
  • Blood Group Antigens
  • Immunoglobulins, Intravenous
  • Thrombocytopenia, Neonatal Alloimmune

abstract

  • FNAIT women with BG-non-O more frequently develop anemia secondary to high-dose IVIG infusion (2 g/kg/week), quite possibly from isohemagglutinin-mediated hemolysis; maternal Hb requires monitoring. IVIG at 1 g/kg/week did not cause anemia in women with BG-non-O; concomitant prednisone likely alleviated the IVIG effect. Maternal BG could influence selection of antenatal treatment for FNAIT.

publication date

  • October 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1111/trf.13779

PubMed ID

  • 27611703

Additional Document Info

start page

  • 2449

end page

  • 2454

volume

  • 56

number

  • 10